Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Chongqing Huapont to Raise $146 Million in Private Placement

publication date: Mar 26, 2012
 Chongqing Huapont Pharmaceutical announced it will raise 920 million RMB ($146 million) in a private placement. The company said it will spend the proceeds on four projects: 300 million RMB ($47.5 million) on a new R&D center; 280 million RMB ($44.3 million) to increase production capacity; 210 million RMB on a topical formulation facility ($33.3 million), leaving 120 million ($19 million) for general corporate use. The company will issue 25 million shares at 32.99 RMB each. More details....

Stock Symbol:  (SHE: 002004)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here